Natural history and predictors of disease severity in chronic hepatitis C.
about
Chronic HCV infection: epidemiological and clinical relevanceHepatitis C virus: A time for decisions. Who should be treated and when?Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysisSocio-demographic and clinical features of Irish iatrogenic hepatitis C patients: a cross-sectional surveyUnhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis CRole of ITPA gene polymorphism in ribavirin-induced anemia and thrombocytopenia in Egyptian patients with chronic hepatitis C.Phlebotomy improves histology in chronic hepatitis C males with mild iron overload.Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.Clinical outcomes of compensated and decompensated cirrhosis: A long term study.Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infectionSignificance of vitamin d receptor gene polymorphisms for risk of hepatocellular carcinoma in chronic hepatitis C.Neutrophil-to-lymphocyte ratio as a predictor of response to peginterferon plus ribavirin therapy for chronic hepatitis C.Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis.The history of the "natural history" of hepatitis C (1968-2009).Hepatitis C in hemodialysis patientsIncreased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation.Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.The high comorbidity burden of the hepatitis C virus infected population in the United States.Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis CHepatitis C virus: a critical appraisal of new approaches to therapy.Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus.Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup.Antiviral treatment of hepatitis C.Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients.Effect of Antiviral Therapy on Serum Activity of Angiotensin Converting Enzyme in Patients with Chronic Hepatitis C.The impact of inosine triphosphatase variants on hemoglobin level and sustained virologic response of chronic hepatitis C in Korean.Epigenetic regulation of hepatic stellate cell activation.Effective use of FibroTest to generate decision trees in hepatitis C.Recognition of genetic factors influencing the progression of hepatitis C : potential for personalized therapy.Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies.Role of hepatitis C virus genotype 3 in liver fibrosis progression--a systematic review and meta-analysis.Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3.Safely treating hepatitis C in patients with HIV or hepatitis B virus coinfection.Stereological assessment of sexual dimorphism in the rat liver reveals differences in hepatocytes and Kupffer cells but not hepatic stellate cells.Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa.Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic?ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C.
P2860
Q21261812-C4EEBDC0-4B84-4034-B469-9252CC5BBAF2Q26768274-E1EFBFA3-2229-4FCC-B315-A9FDCC29EAFFQ26991791-4ADAA1ED-9A8B-45F2-BF6C-43D5134FF771Q27490161-57F129B8-AB1B-4A1F-A449-ACE778E66BCAQ28484313-E1F03B8D-7728-49AE-BF34-CE22B0E2F005Q33430028-04044ADC-5366-4958-B0A8-A508AB66F1C5Q33629438-0C0C5055-EA4D-470A-8B01-BC9C8F51141CQ33853664-545EA792-0A88-4000-91A1-7D145F2A18C8Q33948229-FAC77D69-5B7E-4C34-92C2-7D892C35D4AAQ34008754-96530417-7A66-41FD-8557-FFCBF2B5C844Q34067956-461CD83A-59D4-4677-9768-D2A9AB4BE6DEQ34369199-AC638F2A-BF99-4C60-A097-0CA06E98CB36Q34628015-445C3E34-B9E8-4A32-817C-01DCE2B79447Q35077047-FC93CD29-317E-411A-836A-D5D476FA76DCQ35122925-30B0F60D-3768-4EBE-B87F-F60B5AEDD747Q35216592-3A0677B5-D4CE-4942-91E7-E43C2D1432D8Q35237329-E8099A34-D1D5-40B3-AB89-E1EAA335D4FEQ35609459-7FE63F81-A806-45ED-AB92-0F97DA929162Q35761351-A138B4D6-4E08-402A-8287-13EBDA2C82E1Q35927970-AAB05EE8-A01D-48CF-8AB6-5182CFE39DAFQ35929476-9CFD337E-06D9-49FA-A862-36A7B91EE5ACQ36321008-A53DF7B0-06BD-44D7-AAC3-17D613E59909Q36478562-490F6A2B-93D1-45EB-AB52-40B0AC0CBBCDQ36546657-7328401F-8AFB-4E72-9ECD-98C2EC1F15EBQ36613917-E648543E-E78F-43C8-9324-EC644672C95EQ36799939-7E2AB644-6ABE-4E0C-A9B5-BBC52BD074F7Q36843489-93E37C4E-B88A-45BE-9BB8-25AC8E3181F8Q36853076-715329ED-8A48-48C6-9133-6B13F5EFA850Q37098107-CF6DCFCD-03BA-4DF7-A46B-AEA241801F34Q37108842-C04B17D5-C3E6-4105-B0A0-FD467BB11746Q37214588-C9372291-6BAB-44F3-9520-2112C7DF1481Q37225844-CA4D23C9-66BE-4746-A521-23B200BD83A0Q37355850-AF9E1A4D-F065-4B78-BF19-1F8CAF3864A4Q37944951-DB88C785-075E-4E6B-8E0B-CFC7AB7C2667Q38134774-8E1C50CB-5E38-4586-80C0-38538CCEC1BDQ38392453-A764D8FB-8E6C-4D2E-B7A0-8729AEC84448Q38906172-ED1F0110-56C5-4C1D-A4E3-19E5D920705CQ38932103-842909CB-3F3A-455B-80A0-E3FD791018CDQ38975618-265BDB6E-71CE-4ACC-AE06-085913316708Q38985488-EE5C8DE2-8EF6-4001-AB22-242BC9177C10
P2860
Natural history and predictors of disease severity in chronic hepatitis C.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Natural history and predictors of disease severity in chronic hepatitis C.
@ast
Natural history and predictors of disease severity in chronic hepatitis C.
@en
type
label
Natural history and predictors of disease severity in chronic hepatitis C.
@ast
Natural history and predictors of disease severity in chronic hepatitis C.
@en
prefLabel
Natural history and predictors of disease severity in chronic hepatitis C.
@ast
Natural history and predictors of disease severity in chronic hepatitis C.
@en
P2093
P1476
Natural history and predictors of disease severity in chronic hepatitis C.
@en
P2093
Dominique Thabut
Joseph Moussalli
Julien Massard
Pascal Lebray
Vlad Ratziu
Yves Benhamou
P304
P356
10.1016/J.JHEP.2005.11.009
P433
P577
2005-11-21T00:00:00Z